- Home
- News
- us virgislands
- pharmaceutical intermediate
Pharmaceutical Intermediate Articles & Analysis
15 news found
Versatile compound shows promise in drug synthesis, metal chelation, antioxidant activity, and moreChangsha, China – May 22, 2025– Hunan Huateng Pharmaceutical Co., Ltd., a leading global supplier of PEG derivatives and pharmaceutical intermediates, is proud to offer high-purity N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7) to researchers ...
Changsha, China – 18 March 2025 – Hunan Huateng Pharmaceutical Co., Ltd., a global leader in PEG derivatives and CDMO services for APIs and intermediates, is pleased to announce its participation in CPHI Japan 2025. ...
Always innovative and outstanding, Alfa Chemistry now has an extensive range of products within the pharmaceutical field, including PROTAC building blocks, nucleosides, intermediates and Active Pharmaceutical Ingredients (APIs). ...
With these expanded APIs, we would like to enable pharmaceutical companies all over the world to innovate next-generation therapies for today’s evolving health needs,” said the Chief Scientist of Protheragen-ING. About Protheragen-ING Currently, Protheragen-ING provides products and services like API products, pharmaceutical excipients, veterinary ...
Over the past decade, the use of the freeze-drying process in pharmaceuticals, biopharmaceuticals and nanoderived therapeutics and their translation into commercially viable products has been proven to be highly effective in terms of maintaining the overall stability of pharmaceutical formulations. ...
Huateng Pharma, a leading Contract Development and Manufacturing Organization (CDMO), is proud to announce its comprehensive range of services catering to Veterinary APIs, Pharmaceutical Intermediates, Cosmetic Ingredients, and Specialty & Fine Chemicals. ...
Shanghai, China – June 14, 2024 – Hunan Huateng Pharmaceutical Co., Ltd., a global leader in the production of PEG derivatives and Contract Development and Manufacturing Organization (CDMO) services for Active Pharmaceutical Ingredients (APIs) and intermediates, is excited to announce its participation in CPHI China 2024. ...
This move marks a significant milestone for Protheragen-ING and highlights the company's commitment to collaboration, innovation, and growth within the global pharmaceutical community. By joining forces with DCAT, Protheragen-ING, a supplier of Vitamin C Products, API Products, Pharmaceutical Excipients, Packaging & Equipment, Veterinary Products, aims to ...
Huateng Pharma, a distinguished provider of premium pharmaceutical intermediates, proudly unveils its latest breakthrough: Semaglutide Side Chain. ...
Huateng Pharma proudly announces the launch of a groundbreaking suite of anti-diabetes intermediates, featuring key compounds such as Canagliflozin, Dapagliflozin, Empagliflozin, and Semaglutide. ...
Huateng Pharma, a leading innovator in pharmaceutical intermediates, is proud to announce the introduction of its latest product line - Gastrointestinal API Intermediates, featuring the groundbreaking compounds Fexuprazan and Vonoprazan Intermediates. ...
Its comprehensive fermentation CDMO services and small microbial molecules have delivered tremendous value to the pharmaceutical industry. And the future looks even better. Pharmaceutical enterprises have been confronted with numerous challenges, such as rising cost pressures and uncertainty in the upstream supply of APIs, antibodies, enzymes, therapeutic ...
And in response to this trend, our management decides to introduce a new product line, providing orlistat intermediates CAS NO 104801-96-9 with the most reasonable price,” says the Marketing Chief of Huateng Pharma. ”Previously, we have already been a trust-wothy CDMO for pharmaceutical intermediates, offering custom synthesis and ...
TOKYO and TEL AVIV, Israel, Sept. 30, 2021 /PRNewswire/ -- CytoReason, an AI company developing computational disease models for discovery and clinical drug development, and Summit Pharmaceuticals International (SPI), a Japanese company providing service and products to the pharmaceutical industry (wholly-owned subsidiary of Sumitomo Corporation), today announced ...
Most recently, she led business development at Hovione, a pharmaceutical contract development and manufacturing organization with a focus on active pharmaceutical ingredients and drug product intermediates. ...